Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine–Oxaliplatin With or Without Cetuximab in Advanced Biliary Tract Adenocarcinoma
2007-001200-20Phase 2Active
- Sponsor
- Gustave Roussy
- Start
- Apr 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in Bile duct adenocarcinoma (CCA), sponsored by Gustave Roussy. Started Apr 2007; status: active.
02
Drugs
cetuximab
03
Conditions
Bile duct adenocarcinoma (CCA)
Beyond the preview
Go deeper on 2007-001200-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001200-20.